From the Department of Community Health Sciences (B.M., J.H.-L., T.P., Z.I.), Hotchkiss Brain Institute (J.H.-L., E.E.S., Z.I., Z.G.), O'Brien Institute for Public Health (J.H.-L., Z.G.), Department of Clinical Neurosciences (E.E.S., T.P., Z.I.), Department of Psychiatry (T.P., Z.I.), and Department of Medicine, University of Calgary and Alberta Health Services (J.H.-L, Z.G.), and The Mathison Centre for Mental Health Research and Education (Z.I.), Calgary, Canada.
Neurology. 2018 Jan 2;90(1):e39-e47. doi: 10.1212/WNL.0000000000004771. Epub 2017 Dec 6.
To examine diagnostic accuracy of anxiety detection tools compared with a gold standard in outpatient settings among adults with Parkinson disease (PD).
A systematic review was conducted. MEDLINE, EMABASE, PsycINFO, and Cochrane Database of Systematic Reviews were searched to April 7, 2017. Prevalence of anxiety and diagnostic accuracy measures including sensitivity, specificity, and likelihood ratios were gathered. Pooled prevalence of anxiety was calculated using Mantel-Haenszel-weighted DerSimonian and Laird models.
A total of 6,300 citations were reviewed with 6 full-text articles included for synthesis. Tools included within this study were the Beck Anxiety Inventory, Geriatric Anxiety Inventory (GAI), Hamilton Anxiety Rating Scale, Hospital Anxiety and Depression Scale-Anxiety, Parkinson's Anxiety Scale (PAS), and Mini-Social Phobia Inventory. Anxiety diagnoses made included generalized anxiety disorder, social phobia, and any anxiety type. Pooled prevalence of anxiety was 30.1% (95% confidence interval 26.1%-34.0%). The GAI had the best-reported sensitivity of 0.86 and specificity of 0.88. The observer-rated PAS had a sensitivity of 0.71 and the highest specificity of 0.91.
While there are 6 tools validated for anxiety screening in PD populations, most tools are only validated in single studies. The GAI is brief and easy to use, with a good balance of sensitivity and specificity. The PAS was specifically developed for PD, is brief, and has self-/observer-rated scales, but with lower sensitivity. Health care practitioners involved in PD care need to be aware of available validated tools and choose one that fits their practice.
在帕金森病(PD)门诊环境中,与金标准相比,检查焦虑检测工具对成年人的诊断准确性。
进行了系统评价。检索了 MEDLINE、EMBASE、PsycINFO 和 Cochrane 系统评价数据库,检索时间截至 2017 年 4 月 7 日。收集了焦虑的患病率和诊断准确性指标,包括敏感性、特异性和似然比。使用 Mantel-Haenszel 加权 DerSimonian 和 Laird 模型计算焦虑的汇总患病率。
共审查了 6300 条引文,其中有 6 篇全文文章纳入综合分析。本研究中使用的工具包括贝克焦虑量表、老年焦虑量表(GAI)、汉密尔顿焦虑量表、医院焦虑抑郁量表-焦虑、帕金森焦虑量表(PAS)和迷你社交恐惧症量表。焦虑诊断包括广泛性焦虑障碍、社交恐惧症和任何焦虑类型。焦虑的汇总患病率为 30.1%(95%置信区间 26.1%-34.0%)。GAI 报告的敏感性最高为 0.86,特异性最高为 0.88。观察者评定的 PAS 敏感性为 0.71,特异性最高为 0.91。
虽然有 6 种工具已验证可用于 PD 人群的焦虑筛查,但大多数工具仅在单个研究中得到验证。GAI 简短易用,具有良好的敏感性和特异性平衡。PAS 是专门为 PD 开发的,简短,具有自我/观察者评定量表,但敏感性较低。参与 PD 护理的医疗保健从业者需要了解可用的验证工具,并选择适合其实践的工具。